NFKB1 and Hepatitis: Silybin, a compound of flavonolignans, reduced plasma levels of transaminases and liver content of pro-inflammatory cytokines, inhibited hepatic NF-κB activation, and increased plasma and tissue levels of IL-10 in hepatitis induced by Con A in mouse (Schümann et al., 2003).